These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3623650)

  • 1. Natural killer cell & killer cell activities & circulating immune complexes in patients with breast cancer.
    Seth P; Bose M; Katyal P; Kundu SK; Sharma LK
    Indian J Med Res; 1987 Apr; 85():404-14. PubMed ID: 3623650
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of killer cell activity & circulating immune complex levels in patients with breast cancer.
    Kundu S; Sharma LK; Seth P
    Indian J Med Res; 1988 Oct; 88():330-5. PubMed ID: 3225017
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating immune complex and NK-cell activity in progressive breast cancer.
    Seth R; Seth P
    Breast Cancer Res Treat; 1984; 4(1):54-5. PubMed ID: 6697012
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the immune status of patients with cancer of the stomach].
    Malygin AM; Kurtenkov OA; Miliukhina LM
    Vopr Onkol; 1988; 34(5):549-52. PubMed ID: 3381495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating and tumor tissue-bound immune complexes in patients with breast cancer].
    Dorosevich AE
    Arkh Patol; 1983; 45(7):30-6. PubMed ID: 6354144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphological signs of the blocking effect of immunoglobulins and immune complexes in breast cancer before and after radiotherapy].
    Dorosevich AE
    Arkh Patol; 1988; 50(4):11-6. PubMed ID: 3408365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients.
    Dewan MZ; Takada M; Terunuma H; Deng X; Ahmed S; Yamamoto N; Toi M
    Biomed Pharmacother; 2009 Nov; 63(9):703-6. PubMed ID: 19269774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune complexes in breast cancer].
    Beaufort F; Auner H
    Wien Med Wochenschr; 1983 Feb; 133(3):55-8. PubMed ID: 6342277
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
    Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
    J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes and immunologic reactivity in breast cancer].
    Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
    Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NK (natural killer) and K (killer) cell activity in breast cancer. Relation of the stage of the disease to cytotoxic activity].
    Garam T; Bakács T; Tótpál K; Svastits E; Ringwald G; Petrányi G
    Orv Hetil; 1983 Jan; 124(1):15-8. PubMed ID: 6828317
    [No Abstract]   [Full Text] [Related]  

  • 12. [Circulating immune complexes and cellular cytotoxic reactions in Sjögren's syndrome].
    Nasonov EL; Vasil'ev VI; Aleksandrova EN; Nasonova SV; Timofeeva EB
    Ter Arkh; 1988; 60(4):13-6. PubMed ID: 2969150
    [No Abstract]   [Full Text] [Related]  

  • 13. [Circulating immune complexes and the prognosis of cancer].
    Carpentier N
    Rev Med Suisse Romande; 1983 Jul; 103(7):601-2. PubMed ID: 6635408
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
    Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
    Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production.
    Kubo M; Morisaki T; Matsumoto K; Tasaki A; Yamanaka N; Nakashima H; Kuroki H; Nakamura K; Nakamura M; Katano M
    Cancer Immunol Immunother; 2005 May; 54(5):468-76. PubMed ID: 15592829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection in the blood serum of breast cancer patients of circulating immune complexes containing antigens showing common epitopes with structural proteins of mouse mammary tumour virus (MMTV).
    Malivanova TF; Litvinov SV; Plevaya EB; Kryukova IN
    Acta Virol; 1988 Mar; 32(2):129-37. PubMed ID: 2456679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating immune complexes in the serum of tumor patients].
    Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
    Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune complexes in neoplastic diseases and autoimmune processes].
    Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG; Vygovskaia IaI; Zakharchuk LS
    Vopr Onkol; 1983; 29(8):3-7. PubMed ID: 6613066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
    Ewan PW; Barrett HM; Pusey CD
    J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the effects of hypnosis on the immune system in breast cancer patients: a brief communication.
    Hudacek KD
    Int J Clin Exp Hypn; 2007 Oct; 55(4):411-25. PubMed ID: 17786658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.